QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats

References

• Bao BH, Geng T, Cao YD, Yao WF, Zhang L, Ding AW. 2012. Effects of schizonepetin on activity and mRNA expression of cytochrome P450 enzymes in rats. Int J Mol Sci. 13(12):17006–17018.
   PubMed Web of Science ®Google Scholar
• Brackman DJ, Giacomini KM. 2018. Reverse translational research of ABCG2 (BCRP) in human disease and drug response. Clin Pharmacol Ther. 103(2):233–242.
   PubMed Web of Science ®Google Scholar
• Chang JH, Ly J, Plise E, Zhang XL, Messick K, Wright M, Cheong J. 2014. Differential effects of rifampin and ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3A and Oatp1a/b knockout mice. Drug Metab Dispos. 42(6):1067–1073.
   PubMed Web of Science ®Google Scholar
• Cui YC, Yan L, Pan CS, Hu BH, Chang X, Fan JY, Han JY. 2018. The contribution of different components in QiShenYiQi Pills(R) to its potential to modulate energy metabolism in protection of ischemic myocardial injury. Front Physiol. 9:389.
   PubMed Web of Science ®Google Scholar
• Dong J, Yu X, Wang L, Sun YB, Chen XJ, Wang GJ. 2008. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats. Acta Pharmacol Sin. 29(10):1247–1252.
   PubMed Web of Science ®Google Scholar
• Drozdzik M, Busch D, Lapczuk J, Muller J, Ostrowski M, Kurzawski M, Oswald S. 2019. Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther. 105(5):1204–1212.
   PubMed Web of Science ®Google Scholar
• Fan XH, Shao Q, Yao H, Shi PY, Zhang YF. 2012. Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen Yiqi Pills) in rats. Curr Drug Metab. 13(5):510–523.
   PubMed Web of Science ®Google Scholar
• Feidt DM, Klein K, Hofmann U, Riedmaier S, Knobeloch D, Thasler WE, Weiss TS, Schwab M, Zanger UM. 2010. Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. Drug Metab Dispos. 38(9):1589–1597.
   PubMed Web of Science ®Google Scholar
• Handa K, Nakagome I, Yamaotsu N, Gouda H, Hirono S. 2013. Three-dimensional quantitative structure–activity relationship analysis of inhibitors of human and rat cytochrome P4503A enzymes. Drug Metab Pharmacokinet. 28(4):345–355.
   PubMed Web of Science ®Google Scholar
• Hirota T, Ieiri I. 2015. Drug-drug interactions that interfere with statin metabolism. Expert Opin Drug Metab Toxicol. 11(9):1435–1447.
   PubMed Web of Science ®Google Scholar
• Hu SS, Gao RL, Wang Z, Liu LS, Zhu ML, Wang W, Wang YJ, Wu ZS, Li HJ, Df G, et al. 2019. Report on cardiovascular diseases in China 2018. Beijing (BJ): National Center for Cardiovascular Diseases (China); [accessed 2021 March 31]. https://www.nccd.org.cn/Sites/Uploaded/File/2021/3/%E4%B8%AD%E5%9B%BD%E5%BF%83%E8%A1%80%E7%AE%A1%E7%97%85%E6%8A%A5%E5%91%8A2018%EF%BC%88English%EF%BC%89.pdf.
   Google Scholar
• Hua S, Ma CX, Zhang J, Li J, Wu WW, Xu N, Luo GH, Zhao JR. 2018. Influence of APOA5 locus on the treatment efficacy of three statins: evidence from a randomized pilot study in Chinese subjects. Front Pharmacol. 9:352.
   PubMed Web of Science ®Google Scholar
• Khalilieh S, Yee KL, Sanchez RI, Triantafyllou I, Fan L, Maklad N, Jordan H, Martell M, Iwamoto M. 2017. Results of a doravirine-atorvastatin drug-drug interaction study. Antimicrob Agents Chemother. 61(2):e01364–16.
   PubMed Web of Science ®Google Scholar
• Li K, Lai H. 2017. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters. Biomed Pharmacother. 96:371–377.
   PubMed Web of Science ®Google Scholar
• Li XY, Wu YY, Xu ZY, Chen J, Li YQ, Xing HJ, Zhang XM, Yuan JL. 2020. Effects of Hetiao Jianpi Decoction on intestinal injury and repair in rats with antibiotic-associated diarrhea. Med Sci Monit. 26:e921745.
   PubMed Web of Science ®Google Scholar
• Liu YH, Mo SL, Bi HC, Hu BF, Li CG, Wang YT, Huang L, Huang M, Duan W, Liu JP, et al. 2011. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica. 41(4):259–280.
   PubMed Web of Science ®Google Scholar
• Lv SC, Wu M, Li M, Wang Q, Wang XJ, Zhang A, Xu L, Zhang JP. 2017. Effect of QiShenYiQi pill on myocardial collagen metabolism in experimental autoimmune myocarditis rats. Biomed Pharmacother. 88:894–901.
   PubMed Web of Science ®Google Scholar
• MacLean C, Moenning U, Reichel A, Fricker G. 2008. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats. Drug Metab Dispos. 36(7):1249–1254.
   PubMed Web of Science ®Google Scholar
• Malekinejad H, Rokhsartalab-Azar S, Hassani-Dizaj S, Alizadeh-Fanalou S, Rezabakhsh A, Amniattalab A. 2014. Effects of silymarin on the pharmacokinetics of atorvastatin in diabetic rats. Eur J Drug Metab Pharmacokinet. 39(4):311–320.
   PubMed Web of Science ®Google Scholar
• Morse BL, Alberts JJ, Posada MM, Rehmel J, Kolur A, Tham LS, Loghin C, Hillgren KM, Hall SD, Dickinson GL. 2019. Physiologically-based pharmacokinetic modeling of atorvastatin incorporating delayed gastric emptying and acid-to-lactone conversion. CPT Pharmacometrics Syst Pharmacol. 8(9):664–675.
   PubMedGoogle Scholar
• Murakami T, Takano M. 2008. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol. 4(7):923–939.
   PubMed Web of Science ®Google Scholar
• Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y, Ai H, Wang G. 2008. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos. 36(7):1308–1314.
   PubMed Web of Science ®Google Scholar
• Reiner Z. 2014. Resistance and intolerance to statins. Nutr Metab Cardiovasc Dis. 24(10):1057–1066.
   PubMed Web of Science ®Google Scholar
• Shang HC, Zhang JH, Yao C, Liu BY, Gao XM, Ren M, Gao HB, Dai GH, Weng WL, Zhu SN, et al. 2013. Qi-Shen-Yi-Qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med. 20132013:738391.
   PubMed Web of Science ®Google Scholar
• Shin E, Shin N, Oh JH, Lee YJ. 2017. High-dose metformin may increase the concentration of atorvastatin in the liver by inhibition of multidrug resistance-associated protein 2. J Pharm Sci. 106(4):961–967.
   PubMed Web of Science ®Google Scholar
• Shu N, Hu MY, Liu C, Zhang M, Ling ZL, Zhang J, Xu P, Zhong Z, Chen Y, Liu L, et al. 2016. Decreased exposure of atorvastatin in diabetic rats partly due to induction of hepatic Cyp3A and Oatp2. Xenobiotica. 46(10):875–881.
   PubMed Web of Science ®Google Scholar
• Takada T, Ogino M, Miyata M, Shimada M, Nagata K, Yamazoe Y. 2004. Differences in transactivation between rat CYP3A1 and human CYP3A4 genes by human pregnane X receptor. Drug Metab Pharmacokinet. 19(2):103–113.
   PubMedGoogle Scholar
• Tamai I. 2012. Oral drug delivery utilizing intestinal OATP transporters. Adv Drug Deliv Rev. 64(6):508–514.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Slitt AL, Leazer TM, Maher JM, Klaassen CD. 2005. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem Biophys Res Commun. 326(1):181–187.
   PubMed Web of Science ®Google Scholar
• Ulvestad M, Skottheim IB, Jakobsen GS, Bremer S, Molden E, Asberg A, Hjelmesaeth J, Andersson TB, Sandbu R, Christensen H. 2013. Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects. Clin Pharmacol Ther. 93(3):275–282.
   PubMed Web of Science ®Google Scholar
• Vats R, Varanasi KV, Arla R, Veeraraghavan S, Rajak S, Murthy AN. 2012. Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats. J Pharm Pharmacol. 64(11):1638–1645.
   PubMed Web of Science ®Google Scholar
• Wang QL, Wu Q, Tao YY, Liu CH, El-Nezami H. 2011. Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells. Hepatobiliary Pancreat Dis Int. 10(5):502–508.
   PubMed Web of Science ®Google Scholar
• Wang T, Cui YZ, Jin JJ, Guo JH, Wang GB, Yin XF, He QY, Zhang G. 2013. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res. 41(9):4743–4754.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Feng F. 2019. Evaluation of the hepatotoxicity of the Zhi-Zi-Hou-Po Decoction by combining UPLC-Q-Exactive-MS-Based metabolomics and HPLC-MS/MS-Based geniposide tissue Distribution. Molecules. 24(3):511.
   PubMed Web of Science ®Google Scholar
• Yang J, Hasegawa J, Endo Y, Iitsuka K, Yamamoto M, Matsuda A. 2019. Pharmacokinetic drug interaction between rosuvastatin and Tanjin in healthy volunteers and rats. Yonago Acta Med. 62(1):77–84.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yin RX, Cao XL, Huang F, Zhou YJ, Chen WX. 2018. ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses. Nutr Metab (Lond). 15(1):70.
   PubMedGoogle Scholar
• Yu C, Ye SS, Sun HY, Liu Y, Gao LB, Shen CF, Chen SQ, Zeng S. 2009. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem Biol Interact. 177(1):58–64.
   PubMed Web of Science ®Google Scholar
• Zhang GY, Ou RL, Li FY, Wu JJ, Zheng L, Tong YL, Liu YT, Liu ZQ, Lu LL. 2016. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions. J Ethnopharmacol. 180:104–113.
   PubMed Web of Science ®Google Scholar
• Zhang T. 2015. Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites. Eur J Pharm Sci. 77:216–229.
   PubMed Web of Science ®Google Scholar